KETOROLAC TROMETHAMINE
These highlights do not include all the information needed to use Ketorolac tromethamine ophthalmic solution 0.4% safely and effectively. See full prescribing information for ketorolac tromethamine ophthalmic solution 0.4%. Ketorolac tromethamine ophthalmic solution 0.4% , for topical ophthalmic use Initial U.S. Approval: 1991
Approved
Approval ID
8432a1c5-15e5-4e3d-8e2d-49646e6b7eda
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 5, 2021
Manufacturers
FDA
Pacific Pharma, Inc.
DUNS: 877645267
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Ketorolac Tromethamine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60758-773
Application NumberNDA021528
Product Classification
M
Marketing Category
C73605
G
Generic Name
Ketorolac Tromethamine
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 16, 2023
FDA Product Classification
INGREDIENTS (8)
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT
Ketorolac TromethamineActive
Quantity: 4 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIB
waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
benzalkonium chlorideInactive
Code: F5UM2KM3W7
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
octoxynol-40Inactive
Code: 9T1C662FKS
Classification: IACT